BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01 avr. 2024 16h05 HE
|
Biostem Technologies
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
Alira Health Joins Forces with APMA to Advance Podiatric Registry
27 mars 2024 08h42 HE
|
Alira Health
Framingham, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm, joined the American Podiatric Medical Association (APMA), the largest professional...
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
21 mars 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
CEO of Innovative Outcomes, Inc., (OTC:UBQU) Offers Open Letter to Shareholders and Investors
13 mars 2024 08h00 HE
|
Ubiquitech Software LLC
DENVER, CO, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to offer this open letter to...
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
08 mars 2024 09h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the Bioscience Association of Manitoba...
Ubiquitech Software Corp. (OTC:UBQU) Announces Strategic Acquisition of Innovative Outcomes, Inc., an Established Leader in the Multi-Billion Dollar Medical Wound Care Segment
06 mars 2024 08h00 HE
|
Ubiquitech Software LLC
DENVER, CO, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce its acquisition...
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
26 févr. 2024 10h39 HE
|
PRISM MarketView
PRISM MarketView Highlights BioStem Technologies as it Targets Significant Opportunity in Wound Care Markets
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
22 févr. 2024 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the shareholders...
Coloplast lancerer Biatain® Silicone Fit til sårbehandling og forebyggelse af tryksår i USA
31 janv. 2024 10h00 HE
|
Coloplast A/S
Selskabet sigter efter at udvide sin position inden for avanceret sårbehandling ved at introducere en ny sårbandage, der gavner både sundhedspersonale og patienter. ”Vi introducerer nu dette nye...
Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US
31 janv. 2024 10h00 HE
|
Coloplast A/S
The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients. “We are now introducing new...